EP2211842
AN INHALABLE DRY POWDER FORMULATION COMPRISING GLP-1 FOR USE IN THE TREATMENT OF HYPERGLYCEMIA AND DIABETES BY PULMONARY ADMINISTRATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
24.10.2008EP published:
12.8.2015EP application number:
08841194.7
EPO information:
European Patent Register
Max expiry date:
23.10.2028
Title:
AN INHALABLE DRY POWDER FORMULATION COMPRISING GLP-1 FOR USE IN THE TREATMENT OF HYPERGLYCEMIA AND DIABETES BY PULMONARY ADMINISTRATION
Timeline
Today
24.10.2008EP application
12.8.2015EP Publication
Owner
Name:
MannKind CorporationAddress:
25134 Rye Canyon Loop, 91355, Valencia CA, US
Inventor
Name:
RICHARDSON, PeterAddress:
Ringoes, NJ, US
Name:
BAUGHMAN, Robert, A.Address:
Ridgefield, CT, US
Name:
COSTELLO, DonaldAddress:
Bridgewater, NJ, US
Priority
Number:
982368 PDate:
24.10.2007Country:
US
Number:
985620 PDate:
5.11.2007Country:
US
Number:
33740 PDate:
4.3.2008Country:
US
Number:
52127 PDate:
9.5.2008Country:
US
Classification
Categories:
A61K 9/14, A61K 31/495, A61K 38/26, A61P 3/10